Here's everything you need to know about the new weight loss medication being rolled out by the NHS to treat obesity.

Mounjaro is a medication injection made initially for type 2 ... where it is easiest for you to administer, and where will cause the least complications for you. Once injected, the drug is ...

Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight ...

You take Mounjaro and Ozempic the same way. Both drugs are once-a-week subcutaneous (under the skin) injections. You can administer the injection into your stomach, thigh or upper arm, at any time ...

Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes. Meanwhile, Mounjaro (tirzepatide) is a brand-name subcutaneous injection pen also used to treat type 2 diabetes.

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding weight loss alongside diabetes treatment The Ozempic craze is not yet over.